REAL EXAMPLES / FOUR DIFFERENT JOURNEYS
From assessment
to adoption and value.
Four published examples show the decisions, touchpoints and evidence behind an assessment, customer, patient and product journey.
ASSESSMENT JOURNEY
Zio XT · NICE technology assessment
A published assessment of a remote ECG monitoring service — showing how evidence can support a conditional adoption decision.
- Define the decision
Identify who could benefit from monitoring longer than 24 hours and the relevant standard-care comparator.
- Assess evidence
Review diagnostic yield, patient experience, resource use and remaining uncertainty.
- Make the adoption decision
NICE recommends Zio XT as an option only with specified collection of resource-use and longer-term clinical information.
- Continue learning
Check implementation requirements, including data protection and informed consent; collect the required information.
Executive takeaway
Decision quality depends on evidence, uncertainty and implementation requirements — not a marketing score alone.
NICE · Zio XT guidance, recommendations 1.1–1.3 ↗Paraphrase of the published guidance, not a recommendation for an individual patient or a NUVELO HEALTH regulatory assessment.
CUSTOMER JOURNEY
CeraVe · discovery to a credible brand idea
A reconstruction of the audience journey from WPP’s published 2024 Michael CeraVe campaign.
- Attention
A month-long Michael Cera storyline created curiosity ahead of the Super Bowl.
- Participation
WPP describes 450 influencers, media discussion and participation in the story.
- Brand clarification
The Super Bowl reveal returned attention to CeraVe’s dermatologist-developed positioning.
- Commercial next step
For your own campaign, define a measurable path from attention to product information and purchase. This final step is a NUVELO HEALTH planning suggestion.
Executive takeaway
WPP reports 9bn earned impressions before game day. This does not measure unique people, completed purchases or incremental sales.
WPP / Ogilvy · Michael CeraVe, 2024 ↗This maps a real published campaign, not an observed individual customer’s clickstream. The purchase step is not a reported campaign outcome.
PATIENT JOURNEY
NHS England · Type 2 Diabetes Path to Remission
The published care pathway connects assessment, a structured intervention and continuing support over a 52-week programme.
- Referral & assessment
Clinical eligibility, individual assessment and agreement to participate.
- Supported initial phase
A 12-week total diet replacement phase within the supervised programme.
- Food reintroduction
A stepped six-week transition back to food, tailored to individual needs.
- Maintenance & follow-up
Ongoing support for the remainder of the 52-week programme.
Executive takeaway
The service design requires attention to engagement and completion as well as clinical outcomes; remission is not guaranteed.
NHS England · published service specification (2023), published February 2024 ↗An example of a real supervised service pathway, not self-treatment instructions. Eligibility, medication review and care belong with the clinical team.
PRODUCT JOURNEY
Shingrix · submission, approval and lifecycle
The FDA’s public record shows a product journey with evidence review and continuing regulatory responsibilities.
- Submission
The original US biologics application was dated 21 October 2016.
- Evidence review
The public FDA record includes clinical, statistical and regulatory review documents.
- Initial approval
FDA approved Shingrix on 20 October 2017; the original indication and approved labelling define that decision.
- Lifecycle stewardship
Later approval letters, label updates and safety information appear in the continuing FDA record.
Executive takeaway
Approval is a regulatory milestone. It is not a guarantee of commercial adoption, reimbursement or profit.
FDA · product record, reviews and approval letters ↗US regulatory history, not the EU pathway or a promotion to patients. No NUVELO HEALTH role in this product’s development is implied.
Map the journey
your business needs to improve.
Agree whose journey matters, the decision at each stage, the evidence needed, the owner and the measures. NUVELO HEALTH can connect the commercial roadmap with the relevant specialist inputs.
Discuss your journey map ↗Reviewed 20 October 2026. Published examples above are external; none is presented as a NUVELO HEALTH client engagement.